These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 7715853

  • 1. Effects of repeated administrations of EGF and TGF-alpha on mouse neurobehavioral development.
    Cirulli F, Alleva E.
    Neurotoxicology; 1994; 15(4):819-25. PubMed ID: 7715853
    [Abstract] [Full Text] [Related]

  • 2. Epidermal growth factor (EGF), transforming growth factor-alpha (TGF-alpha), and basic fibroblast growth factor (bFGF) differentially influence neural precursor cells of mouse embryonic mesencephalon.
    Santa-Olalla J, Covarrubias L.
    J Neurosci Res; 1995 Oct 01; 42(2):172-83. PubMed ID: 8568917
    [Abstract] [Full Text] [Related]

  • 3. Central administration of transforming growth factor-alpha and neuregulin-1 suppress active behaviors and cause weight loss in hamsters.
    Snodgrass-Belt P, Gilbert JL, Davis FC.
    Brain Res; 2005 Mar 21; 1038(2):171-82. PubMed ID: 15757633
    [Abstract] [Full Text] [Related]

  • 4. Common behavioral influences of the ErbB1 ligands transforming growth factor alpha and epiregulin administered to mouse neonates.
    Tsuda N, Mizuno M, Yamanaka T, Komurasaki T, Yoshimoto M, Nawa H.
    Brain Dev; 2008 Sep 21; 30(8):533-43. PubMed ID: 18313247
    [Abstract] [Full Text] [Related]

  • 5. Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha.
    Reddy CC, Wells A, Lauffenburger DA.
    J Cell Physiol; 1996 Mar 21; 166(3):512-22. PubMed ID: 8600155
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacological effects of epidermal growth factor (EGF) with focus on the urinary and gastrointestinal tracts.
    Vinter-Jensen L.
    APMIS Suppl; 1999 Mar 21; 93():1-42. PubMed ID: 10424202
    [Abstract] [Full Text] [Related]

  • 10. Epidermal growth factor and transforming growth factor-alpha directly inhibit parietal cell function through a similar mechanism.
    Wang L, Lucey MR, Fras AM, Wilson EJ, Del Valle J.
    J Pharmacol Exp Ther; 1993 Apr 21; 265(1):308-13. PubMed ID: 8474014
    [Abstract] [Full Text] [Related]

  • 11. Epidermal growth factor advances some aspects of development but retards others in both rats and hamsters.
    Smart JL, da Silva VA, Malheiros LR, Paumgartten FJ, Massey RF.
    J Dev Physiol; 1989 Mar 21; 11(3):153-8. PubMed ID: 2809131
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Local effects of EGF, alpha-TGF, and EGF-like growth factors on lobuloalveolar development of the mouse mammary gland in vivo.
    Vonderhaar BK.
    J Cell Physiol; 1987 Sep 21; 132(3):581-4. PubMed ID: 3498730
    [Abstract] [Full Text] [Related]

  • 18. Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein.
    Arteaga CL, Hurd SD, Dugger TC, Winnier AR, Robertson JB.
    Cancer Res; 1994 Sep 01; 54(17):4703-9. PubMed ID: 8062268
    [Abstract] [Full Text] [Related]

  • 19. Aberrant expression and regulation of hepatic epidermal growth factor receptor in a c-myc transgenic mouse model.
    Woitach JT, Conner EA, Wirth PJ, Thorgeirsson SS.
    J Cell Biochem; 1997 Mar 15; 64(4):651-60. PubMed ID: 9093914
    [Abstract] [Full Text] [Related]

  • 20. Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands.
    Dlugosz AA, Cheng C, Williams EK, Darwiche N, Dempsey PJ, Mann B, Dunn AR, Coffey RJ, Yuspa SH.
    Cancer Res; 1995 May 01; 55(9):1883-93. PubMed ID: 7728756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.